TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ATRA

Atara Biotherapeutics Inc

Healthcare · Biotechnology

8.90$ +4.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ATRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-83.37 -36.31 -52.23 -73.25 -102.58 -114.81 -61.09 -58.86 -66.29 -45.55 -9.18 -4.01
0.03 0.05 0.33 0.80 2.13 3.44 2.82 2.49 1.39 1.14 0.67 0.19
50.65 10.02 14.60 19.34 19.30 25.19 17.35 14.38 13.20 10.71 3.61 0.77
54.41 10.11 14.60 19.34 19.42 25.69 17.40 15.37 0.88 – – –
-0.02 6.05 -0.63 6.03 8.56 -2.02 21.52 14.03 -15.07 3.62 -4.13 -8.24
0.23 0.28 2.63 16.94 20.50 2.79 1.53 2.82 1.03 0.29 0.03 0.00
-417.99 -215.11 72.86 82.63 -112.01 29.46 -40.80 5.94 49.75 29.24 1.15 1.43
0.00 0.00 0.00 0.00 – 3.26 0.51 0.33 0.15 – – –
350.66 -4.54 -0.08 -0.30 -4.28 -3.26 -0.51 -0.33 -0.15 -0.02 – –
1.69 -0.52 -0.46 8.29 -0.30 -0.24 -0.13 -0.07 7.37 -0.22 -0.12 -0.02
352.35 253.32 0.44 16.78 204.02 91.99 144.50 27.74 13.01 0.47 7.92 1.27
-149.01 1.81 21.08 26.17 -10.57 6.64 42.61 -25.17 -3.53 -15.84 -0.11 -1.31
-83.60 -36.59 -54.86 -90.19 -123.08 -117.60 -62.61 -61.68 -67.32 -45.84 -9.21 -4.01

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?